Alaina M Jaster
Overview
Explore the profile of Alaina M Jaster including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
14
Citations
133
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Marusak H, Ely S, Zundel C, Gowatch L, Shampine M, Carpenter C, et al.
Psychopharmacology (Berl)
. 2024 Nov;
PMID: 39547971
Background: The endocannabinoid system, which regulates fear- and anxiety-related behaviors, is dysregulated in adults with posttraumatic stress disorder (PTSD), as indicated by higher circulating anandamide (AEA) concentrations. The C385A (rs324420)...
2.
Cameron L, Benetatos J, Lewis V, Bonniwell E, Jaster A, Moliner R, et al.
J Neurosci
. 2023 Nov;
43(45):7472-7482.
PMID: 37940583
Serotonergic psychedelics, such as psilocybin and LSD, have garnered significant attention in recent years for their potential therapeutic effects and unique mechanisms of action. These compounds exert their primary effects...
3.
Jaster A, Gonzalez-Maeso J
Mol Psychiatry
. 2023 Sep;
28(9):3595-3612.
PMID: 37759040
Psychedelics, also known as classical hallucinogens, have been investigated for decades due to their potential therapeutic effects in the treatment of neuropsychiatric and substance use disorders. The results from clinical...
4.
Jaster A, Gonzalez-Maeso J
Methods Mol Biol
. 2023 Jul;
2687:65-76.
PMID: 37464163
Head-twitch response (HTR) allows for the detection and classification of behavior associated with serotonin 2A receptor (5-HTR) activation upon psychedelic administration in rodent models. This activation and functional output can...
5.
Jaster A, Younkin J, Cuddy T, de la Fuente Revenga M, Poklis J, Dozmorov M, et al.
Neurosci Lett
. 2022 Aug;
788:136836.
PMID: 35963476
Psychedelics, also known as classical hallucinogens, affect processes related to perception, cognition and sensory processing mostly via the serotonin 5-HT receptor (5-HTR). This class of psychoactive substances, which includes lysergic...
6.
de la Fuente Revenga M, Jaster A, McGinn J, Silva G, Saha S, Gonzalez-Maeso J
ACS Chem Neurosci
. 2022 Jul;
13(16):2436-2448.
PMID: 35900876
Classical psychedelics represent a subgroup of serotonergic psychoactive substances characterized by their distinct subjective effects on the human psyche. Another unique attribute of this drug class is that such effects...
7.
Jaster A, Elder H, Marsh S, de la Fuente Revenga M, Negus S, Gonzalez-Maeso J
Psychopharmacology (Berl)
. 2022 Mar;
239(6):1665-1677.
PMID: 35233648
Background: Clinical studies suggest that psychedelics exert robust therapeutic benefits in a number of psychiatric conditions including substance use disorder. Preclinical studies focused on safety and efficacy of these compounds...
8.
Jaster A, Gonzalez-Maeso J
Nat Neurosci
. 2021 Dec;
25(1):4-6.
PMID: 34887589
No abstract available.
9.
Jaster A, de la Fuente Revenga M, Gonzalez-Maeso J
J Neurochem
. 2021 Nov;
162(1):80-88.
PMID: 34741320
Psychedelic research across different disciplines and biological levels is growing at a remarkably fast pace. In the prospect of a psychedelic drug becoming again an approved treatment, much of these...
10.
Vohra H, Saunders J, Jaster A, de la Fuente Revenga M, Jimenez J, Fernandez-Teruel A, et al.
Psychopharmacology (Berl)
. 2021 Aug;
239(6):1649-1664.
PMID: 34345931
Background: Prepulse inhibition (PPI) of startle is a sensorimotor gating phenomenon perturbed in a variety of neuropsychiatric conditions. Psychedelics disrupt PPI in rats and humans, but their effects and involvement...